JessicaJayneLiegelMD
Hematology • Boston, MAHematologic Oncology
Instructor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Dr. Liegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
# Shapiro
Boston, MA 02215Phone+1 617-667-2100Fax+1 617-975-5665
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
University of MinnesotaResidency, Internal Medicine/Pediatrics, 2008 - 2012
University of Wisconsin School of Medicine & Public HealthClass of 2008
Certifications & Licensure
MA State Medical License 2014 - 2025
MN State Medical License 2012 - 2018- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 3 citationsPhase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.Anita G Koshy, Haesook T Kim, Jessica Liegel, Jon Arnason, Vincent T Ho
Blood. 2023-06-15 - 15 citationsLeukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, Giulia Cheloni, Beena E Thomas
Haematologica. 2021-02-04 - 46 citationsHypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.Myrna Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia Rachel Pyzer
British Journal of Haematology. 2019-03-03
Abstracts/Posters
- Development of Novel Second Generation DC/Tumor Fusion Vaccine in LymphomaJessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematologi...Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/2019
- CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine ModelJessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- T Cells Educated By DC/AML Fusions in the Context of 4-1BB Costimulation As a Potent Strategy for Adoptive Cellular Therapy61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Transcriptome Sequencing Demonstrates Unique Signature Associated with Durable Clinical Response to DC/AML Fusion Vaccine61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
